MLchartDataset catalogue

Nanoparticle formulation CPI-300

Term · Oncology and biomedicine · MLC-T-ONC-015423

A nanoparticle-based formulation composed of a nanoscale coordination polymer (NCP) complex containing two as of yet undisclosed anti-tumor agents, with potential antineoplastic activities. Upon intravenous administration, nanoparticle formulation CPI-300 delivers the anti-tumor agents to tumor cells, which may lead, through as of yet undisclosed mechanism of actions (MoAs), to specific tumor cell killing and inhibition of proliferation of tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-015423
FieldOncology and biomedicine
Synonymsnanoscale coordination polymer-based formulation CPI-300; NCP platform-based CPI-300
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015423",
  "term": "Nanoparticle formulation CPI-300",
  "field": "Oncology and biomedicine",
  "definition": "A nanoparticle-based formulation composed of a nanoscale coordination polymer (NCP) complex containing two as of yet undisclosed anti-tumor agents, with potential antineoplastic activities. Upon intravenous administration, nanoparticle formulation CPI-300 delivers the anti-tumor agents to tumor cells, which may lead, through as of yet undisclosed mechanism of actions (MoAs), to specific tumor cell killing and inhibition of proliferation of tumor cells.",
  "synonyms": [
    "nanoscale coordination polymer-based formulation CPI-300",
    "NCP platform-based CPI-300"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/nanoparticle-formulation-cpi-300/"
}

Record 11,575 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.